A carregar...
Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysis
Hypomagnesemia is a serious adverse event for patients treated with cetuximab, an inhibitor of endothelial growth factor receptor (EGFR). However, no significant association has yet been established between cetuximab and hypomagnesemia in randomized controlled clinical trials (RCTs). The present stu...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3700916/ https://ncbi.nlm.nih.gov/pubmed/23833666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1301 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|